Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 3;9(1):00217-2022.
doi: 10.1183/23120541.00217-2022. eCollection 2023 Jan.

All-cause admissions following a first ever exacerbation-related hospitalisation in COPD

Affiliations

All-cause admissions following a first ever exacerbation-related hospitalisation in COPD

Kiki Waeijen-Smit et al. ERJ Open Res. .

Abstract

Background: Hospital admissions are important contributors to the overall burden of chronic obstructive pulmonary disease (COPD). Understanding the patterns and causes of hospital admissions will help to identify targets for preventive interventions. This study aimed to determine the 5-year all-cause hospital admission trajectories of patients with COPD following their first ever exacerbation-related hospitalisation.

Methods: Patients with COPD were identified from the Danish national registries. Patients experiencing their first ever exacerbation-related hospitalisation, defined as the index event, between 2000 and 2014 were included. All-cause hospital admissions were examined during a subsequent 5-year follow-up period, and categorised using the International Classification of Diseases, 10th revision.

Results: In total, 82 964 patients with COPD were included. The mean±sd age was 72±10 years and 48% were male. Comorbidities were present in 58%, and 65% of the patients collected inhalation medication ≤6 months prior to the index event. In total, 337 066 all-cause hospital admissions were identified, resulting in a 5-year admission rate of 82%. Most admissions were due to nonrespiratory causes (59%), amongst which cardiac events were most common (19%).

Conclusion: Hospital admissions following a first exacerbation-related hospitalisation are common; nonrespiratory events constitute the majority of admissions. Besides the respiratory causes, treatment targeting the nonrespiratory causes of hospital admission should be considered to effectively decrease the burden of hospitalisation in COPD.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: S.O. Simons has received grants and personal fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Chiesi outside the submitted work. F.M.E. Franssen has received grants and personal fees from AstraZeneca, Chiesi, Boehringer Ingelheim, Glaxosmithkline, Novartis and MSD outside the submitted work. M.A. Spruit has received grants and personal fees from the Netherlands Lung Foundation, Stichting Asthma Bestrijding, AstraZeneca, Boehringer Ingeheim, TEVA and CHIESI outside the submitted work. C.T. Pedersen has received grants from Bayer and Novo Nordisk outside the submitted work. All authors declare no conflicts of interest in relation to the present study.

Figures

FIGURE 1
FIGURE 1
Flowchart of the study population.
FIGURE 2
FIGURE 2
a) 5-year cumulative incidence of experiencing a first all-cause hospital admission after hospital discharge from the index event. b) 5-year survival probability.
FIGURE 3
FIGURE 3
Mean cumulative count of subsequent hospital admissions during the 5-year follow-up.
FIGURE 4
FIGURE 4
Sankey diagram displaying the diagnoses of the first three hospital admissions after the index event. Data are presented as n (%).
FIGURE 5
FIGURE 5
Specific diagnoses of the two most common causes of hospital admission at the end of the 5-year follow-up. Relative percentages of the total number of admissions are presented. a) Specific diagnoses of the 139 272 respiratory-related admissions. b) Specific diagnoses of the 36 586 cardiac-related admissions. International Classification of Diseases (10th Revision) codes are given in parentheses.

References

    1. Hurst JR, Skolnik N, Hansen GJ, et al. Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life. Eur J Intern Med 2020; 73: 1–6. doi: 10.1016/j.ejim.2019.12.014 - DOI - PubMed
    1. Vogelmeier CF, Diesing J, Kossack N, et al. COPD Exacerbation history and impact on future exacerbations – 8-year retrospective observational database cohort study from Germany. Int J Chron Obstruct Pulmon Dis 2021; 16: 2407–2417. doi: 10.2147/COPD.S322036 - DOI - PMC - PubMed
    1. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128–1138. doi: 10.1056/NEJMoa0909883 - DOI - PubMed
    1. Steer J, Norman EM, Afolabi OA, et al. Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax 2012; 67: 117–121. doi: 10.1136/thoraxjnl-2011-200332 - DOI - PubMed
    1. Almagro P, Calbo E, de Echaguïen AO, et al. Mortality after hospitalization for COPD. Chest 2002; 121: 1441–1448. doi: 10.1378/chest.121.5.1441 - DOI - PubMed

LinkOut - more resources